2014
DOI: 10.1038/nrc3816
|View full text |Cite|
|
Sign up to set email alerts
|

Hypermutation in human cancer genomes: footprints and mechanisms

Abstract: Preface A role for somatic mutations in carcinogenesis is well accepted, but the degree to which mutation rates influence cancer initiation and development is under continuous debate. Recently accumulated genomic data has revealed that thousands of tumour samples are riddled by hypermutation, broadening support that cancers acquire a mutator phenotype. This major expansion of cancer mutation data sets has provided unprecedented statistical power for the analysis of mutation spectra, which has confirmed several… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

6
336
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 368 publications
(348 citation statements)
references
References 165 publications
6
336
0
1
Order By: Relevance
“…Recent advances in sequencing technology revealed the landscape of genetic aberrations in human cancers (9). The abundant information on mutation signatures in various cancers provides a clue to the molecular processes involved in genetic aberrations during carcinogenesis.…”
Section: Introductionmentioning
confidence: 99%
“…Recent advances in sequencing technology revealed the landscape of genetic aberrations in human cancers (9). The abundant information on mutation signatures in various cancers provides a clue to the molecular processes involved in genetic aberrations during carcinogenesis.…”
Section: Introductionmentioning
confidence: 99%
“…Many of the mutations in human tumors display "signatures" of APOBEC3 family deaminases (33,34). In particular, a signature defined by C to T or C to G mutations in TCW context (W is A or T) is found in the genomes of a number of different cancers and is attributed to mutations caused by APOBEC3 enzymes (33,35,36). As in E. coli, C:G to T:A mutations in tumors would be caused when uracils created in LGST by one of the APOBEC3s are copied by the replicative DNA polymerases δ, or when AP sites created by the excision of uracils by UNG2 are copied by polymerase η, resulting in an insertion of adenines (37).…”
mentioning
confidence: 99%
“…UV mutation signatures have been described in melanomas and non-melanoma skin cancers (Pfeifer et al, 2012;Griewank et al 2013, Roberts et al, 2014.…”
Section: Mechanistic Studiesmentioning
confidence: 99%